 | • レポートコード：D0GIR-01363 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、新型コロナウイルス感染症薬物APIの世界市場を広く調査・分析し、今後の市場展望をまとめております。新型コロナウイルス感染症薬物APIの種類別市場規模（ヒドロキシクロロキン、クロロキンリン酸、その他）、用途別市場規模（錠剤、注射）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Shanghai Zhongxi Sunve Pharma Co., Ltd.、Wuhan Wuyao Pharmaceutical Co., Ltd、Cinkate、Fuan Pharmaceutical Group、Chongqing Kangle Pharmaceutical Co., Ltd.、Shenhua Pharmaceutical Co., Ltd ・地域別グローバル市場分析 2015年-2020年 ・新型コロナウイルス感染症薬物APIの北米市場（アメリカ、カナダ、メキシコ） ・新型コロナウイルス感染症薬物APIのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・新型コロナウイルス感染症薬物APIのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・新型コロナウイルス感染症薬物APIの南米市場（ブラジル、アルゼンチン） ・新型コロナウイルス感染症薬物APIの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヒドロキシクロロキン、クロロキンリン酸、その他 ・用途別分析：錠剤、注射 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The COVID-19 Drug API market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global COVID-19 Drug API sales will be xx in 2020 from COVID-19 Drug API million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global COVID-19 Drug API market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the COVID-19 Drug API industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on COVID-19 Drug API and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
COVID-19 Drug API market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, COVID-19 Drug API market has been segmented into:
Hydroxychloroquine
Chloroquine Phosphate
Others
By Application, COVID-19 Drug API has been segmented into:
Tablet
Injection
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global COVID-19 Drug API market presented in the report. This section sheds light on the sales growth of different regional and country-level COVID-19 Drug API markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global COVID-19 Drug API market.
The report offers in-depth assessment of the growth and other aspects of the COVID-19 Drug API market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and COVID-19 Drug API Market Share Analysis
COVID-19 Drug API competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, COVID-19 Drug API sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the COVID-19 Drug API sales, revenue and market share for each player covered in this report.
The major players covered in COVID-19 Drug API are:
Shanghai Zhongxi Sunve Pharma Co., Ltd.
Wuhan Wuyao Pharmaceutical Co., Ltd
Cinkate
Fuan Pharmaceutical Group
Chongqing Kangle Pharmaceutical Co., Ltd.
Shenhua Pharmaceutical Co., Ltd
Among other players domestic and global, COVID-19 Drug API market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 COVID-19 Drug API Market Overview
1.1 Product Overview and Scope of COVID-19 Drug API
1.2 Classification of COVID-19 Drug API by Type
1.2.1 Global COVID-19 Drug API Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global COVID-19 Drug API Revenue Market Share by Type in 2019
1.2.3 Hydroxychloroquine
1.2.4 Chloroquine Phosphate
1.2.5 Others
1.3 Global COVID-19 Drug API Market by Application
1.3.1 Overview: Global COVID-19 Drug API Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Tablet
1.3.3 Injection
1.4 Global COVID-19 Drug API Market by Regions
1.4.1 Global COVID-19 Drug API Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of COVID-19 Drug API (2015-2025)
1.4.3 North America (USA, Canada and Mexico) COVID-19 Drug API Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) COVID-19 Drug API Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) COVID-19 Drug API Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) COVID-19 Drug API Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) COVID-19 Drug API Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: COVID-19 Drug API Industry Impact
1.5.1 COVID-19 Potential Implications for the COVID-19 Drug API
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on COVID-19 Drug API
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Shanghai Zhongxi Sunve Pharma Co., Ltd.
2.1.1 Shanghai Zhongxi Sunve Pharma Co., Ltd. Details
2.1.2 Shanghai Zhongxi Sunve Pharma Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Shanghai Zhongxi Sunve Pharma Co., Ltd. SWOT Analysis
2.1.4 Shanghai Zhongxi Sunve Pharma Co., Ltd. Product and Services
2.1.5 Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2019)
2.2 Wuhan Wuyao Pharmaceutical Co., Ltd
2.2.1 Wuhan Wuyao Pharmaceutical Co., Ltd Details
2.2.2 Wuhan Wuyao Pharmaceutical Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Wuhan Wuyao Pharmaceutical Co., Ltd SWOT Analysis
2.2.4 Wuhan Wuyao Pharmaceutical Co., Ltd Product and Services
2.2.5 Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2019)
2.3 Cinkate
2.3.1 Cinkate Details
2.3.2 Cinkate Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Cinkate SWOT Analysis
2.3.4 Cinkate Product and Services
2.3.5 Cinkate COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2019)
2.4 Fuan Pharmaceutical Group
2.4.1 Fuan Pharmaceutical Group Details
2.4.2 Fuan Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Fuan Pharmaceutical Group SWOT Analysis
2.4.4 Fuan Pharmaceutical Group Product and Services
2.4.5 Fuan Pharmaceutical Group COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2019)
2.5 Chongqing Kangle Pharmaceutical Co., Ltd.
2.5.1 Chongqing Kangle Pharmaceutical Co., Ltd. Details
2.5.2 Chongqing Kangle Pharmaceutical Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Chongqing Kangle Pharmaceutical Co., Ltd. SWOT Analysis
2.5.4 Chongqing Kangle Pharmaceutical Co., Ltd. Product and Services
2.5.5 Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2019)
2.6 Shenhua Pharmaceutical Co., Ltd
2.6.1 Shenhua Pharmaceutical Co., Ltd Details
2.6.2 Shenhua Pharmaceutical Co., Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Shenhua Pharmaceutical Co., Ltd SWOT Analysis
2.6.4 Shenhua Pharmaceutical Co., Ltd Product and Services
2.6.5 Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global COVID-19 Drug API Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 COVID-19 Drug API Players Market Share
3.2.2 Top 10 COVID-19 Drug API Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global COVID-19 Drug API Revenue and Market Share by Regions
4.2 North America COVID-19 Drug API Revenue and Growth Rate (2015-2020)
4.3 Europe COVID-19 Drug API Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific COVID-19 Drug API Revenue and Growth Rate (2015-2020)
4.5 South America COVID-19 Drug API Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa COVID-19 Drug API Revenue and Growth Rate (2015-2020)
5 North America COVID-19 Drug API Revenue by Countries
5.1 North America COVID-19 Drug API Revenue by Countries (2015-2020)
5.2 USA COVID-19 Drug API Revenue and Growth Rate (2015-2020)
5.3 Canada COVID-19 Drug API Revenue and Growth Rate (2015-2020)
5.4 Mexico COVID-19 Drug API Revenue and Growth Rate (2015-2020)
6 Europe COVID-19 Drug API Revenue by Countries
6.1 Europe COVID-19 Drug API Revenue by Countries (2015-2020)
6.2 Germany COVID-19 Drug API Revenue and Growth Rate (2015-2020)
6.3 UK COVID-19 Drug API Revenue and Growth Rate (2015-2020)
6.4 France COVID-19 Drug API Revenue and Growth Rate (2015-2020)
6.5 Russia COVID-19 Drug API Revenue and Growth Rate (2015-2020)
6.6 Italy COVID-19 Drug API Revenue and Growth Rate (2015-2020)
7 Asia-Pacific COVID-19 Drug API Revenue by Countries
7.1 Asia-Pacific COVID-19 Drug API Revenue by Countries (2015-2020)
7.2 China COVID-19 Drug API Revenue and Growth Rate (2015-2020)
7.3 Japan COVID-19 Drug API Revenue and Growth Rate (2015-2020)
7.4 Korea COVID-19 Drug API Revenue and Growth Rate (2015-2020)
7.5 India COVID-19 Drug API Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia COVID-19 Drug API Revenue and Growth Rate (2015-2020)
8 South America COVID-19 Drug API Revenue by Countries
8.1 South America COVID-19 Drug API Revenue by Countries (2015-2020)
8.2 Brazil COVID-19 Drug API Revenue and Growth Rate (2015-2020)
8.3 Argentina COVID-19 Drug API Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue COVID-19 Drug API by Countries
9.1 Middle East & Africa COVID-19 Drug API Revenue by Countries (2015-2020)
9.2 Saudi Arabia COVID-19 Drug API Revenue and Growth Rate (2015-2020)
9.3 UAE COVID-19 Drug API Revenue and Growth Rate (2015-2020)
9.4 Egypt COVID-19 Drug API Revenue and Growth Rate (2015-2020)
9.5 South Africa COVID-19 Drug API Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global COVID-19 Drug API Revenue and Market Share by Type (2015-2020)
10.2 Global COVID-19 Drug API Market Forecast by Type (2019-2024)
10.3 Hydroxychloroquine Revenue Growth Rate (2015-2025)
10.4 Chloroquine Phosphate Revenue Growth Rate (2015-2025)
10.5 Others Revenue Growth Rate (2015-2025)
11 Global COVID-19 Drug API Market Segment by Application
11.1 Global COVID-19 Drug API Revenue Market Share by Application (2015-2020)
11.2 COVID-19 Drug API Market Forecast by Application (2019-2024)
11.3 Tablet Revenue Growth (2015-2020)
11.4 Injection Revenue Growth (2015-2020)
12 Global COVID-19 Drug API Market Size Forecast (2021-2025)
12.1 Global COVID-19 Drug API Market Size Forecast (2021-2025)
12.2 Global COVID-19 Drug API Market Forecast by Regions (2021-2025)
12.3 North America COVID-19 Drug API Revenue Market Forecast (2021-2025)
12.4 Europe COVID-19 Drug API Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific COVID-19 Drug API Revenue Market Forecast (2021-2025)
12.6 South America COVID-19 Drug API Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa COVID-19 Drug API Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global COVID-19 Drug API Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of COVID-19 Drug API by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global COVID-19 Drug API Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market COVID-19 Drug API Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global COVID-19 Drug API Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Shanghai Zhongxi Sunve Pharma Co., Ltd. Corporate Information, Location and Competitors
Table 7. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Major Business
Table 8. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Total Revenue (USD Million) (2017-2018)
Table 9. Shanghai Zhongxi Sunve Pharma Co., Ltd. SWOT Analysis
Table 10. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Product and Solutions
Table 11. Shanghai Zhongxi Sunve Pharma Co., Ltd. COVID-19 Drug API Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Wuhan Wuyao Pharmaceutical Co., Ltd Corporate Information, Location and Competitors
Table 13. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Major Business
Table 14. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Total Revenue (USD Million) (2018-2019)
Table 15. Wuhan Wuyao Pharmaceutical Co., Ltd SWOT Analysis
Table 16. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Product and Solutions
Table 17. Wuhan Wuyao Pharmaceutical Co., Ltd COVID-19 Drug API Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Cinkate Corporate Information, Location and Competitors
Table 19. Cinkate COVID-19 Drug API Major Business
Table 20. Cinkate COVID-19 Drug API Total Revenue (USD Million) (2017-2018)
Table 21. Cinkate SWOT Analysis
Table 22. Cinkate COVID-19 Drug API Product and Solutions
Table 23. Cinkate COVID-19 Drug API Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Fuan Pharmaceutical Group Corporate Information, Location and Competitors
Table 25. Fuan Pharmaceutical Group COVID-19 Drug API Major Business
Table 26. Fuan Pharmaceutical Group COVID-19 Drug API Total Revenue (USD Million) (2017-2018)
Table 27. Fuan Pharmaceutical Group SWOT Analysis
Table 28. Fuan Pharmaceutical Group COVID-19 Drug API Product and Solutions
Table 29. Fuan Pharmaceutical Group COVID-19 Drug API Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Chongqing Kangle Pharmaceutical Co., Ltd. Corporate Information, Location and Competitors
Table 31. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Major Business
Table 32. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Total Revenue (USD Million) (2017-2018)
Table 33. Chongqing Kangle Pharmaceutical Co., Ltd. SWOT Analysis
Table 34. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Product and Solutions
Table 35. Chongqing Kangle Pharmaceutical Co., Ltd. COVID-19 Drug API Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Shenhua Pharmaceutical Co., Ltd Corporate Information, Location and Competitors
Table 37. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Major Business
Table 38. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Total Revenue (USD Million) (2017-2018)
Table 39. Shenhua Pharmaceutical Co., Ltd SWOT Analysis
Table 40. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Product and Solutions
Table 41. Shenhua Pharmaceutical Co., Ltd COVID-19 Drug API Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global COVID-19 Drug API Revenue (Million USD) by Players (2015-2020)
Table 43. Global COVID-19 Drug API Revenue Share by Players (2015-2020)
Table 44. Global COVID-19 Drug API Revenue (Million USD) by Regions (2015-2020)
Table 45. Global COVID-19 Drug API Revenue Market Share by Regions (2015-2020)
Table 46. North America COVID-19 Drug API Revenue by Countries (2015-2020)
Table 47. North America COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Table 48. Europe COVID-19 Drug API Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific COVID-19 Drug API Revenue (Million USD) by Countries (2015-2020)
Table 50. South America COVID-19 Drug API Revenue by Countries (2015-2020)
Table 51. South America COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa COVID-19 Drug API Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Table 54. Global COVID-19 Drug API Revenue (Million USD) by Type (2015-2020)
Table 55. Global COVID-19 Drug API Revenue Share by Type (2015-2020)
Table 56. Global COVID-19 Drug API Revenue Forecast by Type (2021-2025)
Table 57. Global COVID-19 Drug API Revenue by Application (2015-2020)
Table 58. Global COVID-19 Drug API Revenue Share by Application (2015-2020)
Table 59. Global COVID-19 Drug API Revenue Forecast by Application (2021-2025)
Table 60. Global COVID-19 Drug API Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. COVID-19 Drug API Picture
Figure 2. Global COVID-19 Drug API Revenue Market Share by Type in 2019
Figure 3. Hydroxychloroquine Picture
Figure 4. Chloroquine Phosphate Picture
Figure 5. Others Picture
Figure 6. COVID-19 Drug API Revenue Market Share by Application in 2019
Figure 7. Tablet Picture
Figure 8. Injection Picture
Figure 9. Global COVID-19 Drug API Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America COVID-19 Drug API Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe COVID-19 Drug API Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific COVID-19 Drug API Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America COVID-19 Drug API Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa COVID-19 Drug API Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global COVID-19 Drug API Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global COVID-19 Drug API Revenue Share by Players in 2019
Figure 17. Global Top 5 Players COVID-19 Drug API Revenue Market Share in 2019
Figure 18. Global Top 10 Players COVID-19 Drug API Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global COVID-19 Drug API Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global COVID-19 Drug API Revenue Market Share by Regions (2015-2020)
Figure 22. Global COVID-19 Drug API Revenue Market Share by Regions in 2018
Figure 23. North America COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 24. Europe COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 26. South America COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 28. North America COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Figure 29. North America COVID-19 Drug API Revenue Market Share by Countries in 2019
Figure 30. USA COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 31. Canada COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 32. Mexico COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 33. Europe COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Figure 34. Europe COVID-19 Drug API Revenue Market Share by Countries in 2019
Figure 35. Germany COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 36. UK COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 37. France COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 38. Russia COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 39. Italy COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific COVID-19 Drug API Revenue Market Share by Countries in 2019
Figure 42. China COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 43. Japan COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 44. Korea COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 45. India COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 47. South America COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Figure 48. South America COVID-19 Drug API Revenue Market Share by Countries in 2019
Figure 49. Brazil COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 50. Argentina COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa COVID-19 Drug API Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa COVID-19 Drug API Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 54. UAE COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 55. Egypt COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 56. South Africa COVID-19 Drug API Revenue and Growth Rate (2015-2020)
Figure 57. Global COVID-19 Drug API Revenue Share by Type (2015-2020)
Figure 58. Global COVID-19 Drug API Revenue Share by Type in 2019
Figure 59. Global COVID-19 Drug API Market Share Forecast by Type (2021-2025)
Figure 60. Global Hydroxychloroquine Revenue Growth Rate (2015-2020)
Figure 61. Global Chloroquine Phosphate Revenue Growth Rate (2015-2020)
Figure 62. Global Others Revenue Growth Rate (2015-2020)
Figure 63. Global COVID-19 Drug API Revenue Share by Application (2015-2020)
Figure 64. Global COVID-19 Drug API Revenue Share by Application in 2019
Figure 65. Global COVID-19 Drug API Market Share Forecast by Application (2021-2025)
Figure 66. Global Tablet Revenue Growth Rate (2015-2020)
Figure 67. Global Injection Revenue Growth Rate (2015-2020)
Figure 68. Global COVID-19 Drug API Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global COVID-19 Drug API Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global COVID-19 Drug API Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America COVID-19 Drug API Revenue Market Forecast (2021-2025)
Figure 72. Europe COVID-19 Drug API Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific COVID-19 Drug API Revenue Market Forecast (2021-2025)
Figure 74. South America COVID-19 Drug API Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa COVID-19 Drug API Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
新型コロナウイルス感染症用クロロキン薬剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chloroquine Drug for COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…- クロロキン薬剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Chloroquine Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- プロスタサイクリン薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Prostacyclin Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tra…
- 薬物再プロファイリングの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Drug Reprofiling market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trad…
- 薬物安定性試験室の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Drug Stability Test Chamber market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…